Clinical Neurology and Neurosurgery
Volume 112, Issue 6 , Pages 463-466, July 2010

Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine

Division of Neurology and Epidemiology, Federal University of Bahia, Av Reitor Miguel Calmon, s/n, Salvador, Bahia, Brazil

Received 28 April 2009; received in revised form 21 January 2010; accepted 7 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0303-8467(10)00036-3

doi:10.1016/j.clineuro.2010.02.004

Clinical Neurology and Neurosurgery
Volume 112, Issue 6 , Pages 463-466, July 2010

Article Tools

* Image Usage & Resolution